These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2047050)

  • 1. Effect of long-term triphasic oral contraceptive use on glucose tolerance and insulin secretion.
    Gillespy M; Notelovitz M; Ellingson AB; Khan FY
    Obstet Gynecol; 1991 Jul; 78(1):108-14. PubMed ID: 2047050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of different contraceptive treatments on the serum concentration of dehydroepiandrosterone sulfate.
    Klove KL; Roy S; Lobo RA
    Contraception; 1984 Apr; 29(4):319-24. PubMed ID: 6235099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of carbohydrate metabolism in women using a triphasic oral contraceptive containing norethindrone and ethinyl estradiol for 3 months.
    Spellacy WN; Ellingson AB; Kotlik A; Tsibris JC
    Am J Obstet Gynecol; 1988 Oct; 159(4):877-9. PubMed ID: 3052079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives and insulin receptor binding in normal women and those with previous gestational diabetes.
    Skouby SO; Andersen O; Kühl C
    Am J Obstet Gynecol; 1986 Oct; 155(4):802-7. PubMed ID: 3766633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
    Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V
    J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative study of the pregnancy zone protein in sera of woman taking oral contraceptives.
    Damber MG; von Schoultz B; Solheim F; Stigbrand T
    Am J Obstet Gynecol; 1976 Feb; 124(3):289-92. PubMed ID: 55075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term profile of a new progestin.
    Lippman J
    Int J Fertil; 1992; 37 Suppl 4():218-22. PubMed ID: 1362189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral contraceptives on carbohydrate metabolism.
    Wynn V; Godsland I
    J Reprod Med; 1986 Sep; 31(9 Suppl):892-7. PubMed ID: 3095547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of oral contraceptives on plasma insulin and blood glucose levels after long term use (author's transl)].
    Muck BR; Hommel G
    Arch Gynakol; 1976; 221(1):61-72. PubMed ID: 989269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral contraceptives on vitamin B6 nutriture of young women.
    Vir SC; Love AH
    Int J Vitam Nutr Res; 1980; 50(1):29-34. PubMed ID: 7390712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbohydrate metabolic studies in women using a levonorgestrel/ethinyl estradiol containing triphasic oral contraceptive for eighteen months.
    Spellacy WN; Tsibris JC; Ellingson AB
    Int J Gynaecol Obstet; 1991 May; 35(1):69-71. PubMed ID: 1680079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of metabolic effects of a triphasic formulation containing norethindrone in normal women studied prospectively.
    Toth EL; Ryan EA
    Contraception; 1988 Jun; 37(6):549-54. PubMed ID: 3293908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose and insulin levels after six months of treatment with a triphasic oral contraceptive containing ethinyl estradiol and norethindrone.
    Spellacy WN; Ellingson AB; Tsibris JC
    J Reprod Med; 1989 Aug; 34(8):540-2. PubMed ID: 2681750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triphasic oral contraception: metabolic effects in normal women and those with previous gestational diabetes.
    Skouby SO; Kühl C; Mølsted-Pedersen L; Petersen K; Christensen MS
    Am J Obstet Gynecol; 1985 Nov; 153(5):495-500. PubMed ID: 3933351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbohydrate metabolism studies in women using Brevicon, a low-estrogen type of oral contraceptive, for one year.
    Spellacy WN; Buhi WC; Birk SA; Van Arnarn JB
    Am J Obstet Gynecol; 1982 Jan; 142(1):105-8. PubMed ID: 7034537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral alanine loads on plasma amino acids in oral contraceptive users and control women.
    Potera C; Rose DP
    Am J Clin Nutr; 1978 May; 31(5):794-8. PubMed ID: 645627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.